Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
congress
2
×
crispr
detroit blog main
detroit top stories
eli lilly
fda
gene editing
glaxosmithkline
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
advaxis
aimmune therapeutics
alder biopharmaceuticals
alector
alexander hardy
alkermes
andrew oxtoby
avrobio
babies
baricitinib
What
bio
crispr
2
×
roundup
big
biopharma
bosley's
bosley’s
bridge
bucks
cas
ceo
congress
congressional
crime
departure
editas
executives
exit
feud
group
guiding
isn’t
katrine
known
later
medicine
month
moves
new
ny
personnel
pharma
roster
spectacles
splash
stay
surprising
testify
tuned
vs
Language
Current search:
congress
×
crispr
×
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More